#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy Peripheral primitive neuroectodermal tumour of soft tissue Rheumatoid arthritis Anal cancer Usher's syndrome Hydrocephalus Mantle cell lymphoma stage II Neoplasm Soft tissue sarcoma Immune-mediated myositis Osteosarcoma recurrent Rett syndrome Aicardi-Goutieres syndrome Leukaemia Deafness bilateral More trials…

    Learn about Rare Diseases

    Synovial sarcoma – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Haemophilia A without inhibitors – Treatment Rhabdoid tumour – Diagnostics Familial amyotrophic lateral sclerosis Mantle cell lymphoma refractory Gaucher’s disease type III Alagille syndrome – Trials in Disease Myxofibrosarcoma – Basic Information MELAS syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NERANDOMILAST Acalabrutinib VISUGROMAB Mebufotenin Prucalopride Ds-3939A ATIGOTATUG Azd0901 Argon Stiripentol 12 Grass Pollen Mixture RNMB1 Biotin Theophylline S095035 Azithromycin Clindamycin Lansoprazole Inclisiran Sodium Resmetirom More therapies…

    Learn about Your Condition

    Bile duct cancer Irritable bowel syndrome Cholangiocarcinoma Brain abscess Ovarian cancer stage III Procedural headache Pancreatic neoplasm Dyspepsia Retinal artery occlusion Drug dependence Postoperative delirium Agitation Plasma cell myeloma recurrent Chronic myeloid leukaemia Astrocytoma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effect of Botulinum Toxin Type A and Physiological NaCl 0.9% in Patients with Piriformis Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Piriformis syndrome
    Investigated Drugs:
    • Botulinum Toxin Type A
    The Netherlands

  • Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
    • Tigulixostat
    Belgium Bulgaria Czechia France Germany Italy +3

  • Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Dronabinol
    • Pantoprazole
    • Ibuprofen
    Czechia Germany Poland Spain

  • Study on Immunosuppressive Therapies with Asfotase Alfa for Patients with Hypophosphatasia Experiencing Reduced Treatment Effectiveness

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Asfotase Alfa
    • Human Normal Immunoglobulin (Iv)
    • Bortezomib
    France

  • Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Frexalimab
    Greece Hungary Italy Spain

  • Study on the Effects of EDG-5506 in Adults with Becker Muscular Dystrophy, McArdle Disease, or Limb-Girdle Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Glycogen storage disease type V
    • Becker’s muscular dystrophy
    • Muscular dystrophy
    Investigated Drugs:
    • Edg-5506
    Denmark
Previous Page
1 … 60 61 62 63 64 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!